An overview of the epidemiology of hypersensitivity drug reactions

被引:2
作者
Bousquet, PJ [1 ]
Demoly, P [1 ]
机构
[1] Univ Montpellier, INSERM, Serv Maladies Resp, U454,Hop Arnaud Villeneuve, F-34295 Montpellier 05, France
来源
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE | 2005年 / 45卷 / 08期
关键词
adverse drug reactions; drug allergy; epidemiology;
D O I
10.1016/j.allerg.2005.09.010
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Hypersensitivity reactions are but one of many different types of adverse drug reactions. Reactions of this type may be potentially lifethreatening, induce and prolong hospitalization, affect physicians' drug prescribing patterns and result in considerable socioeconomic costs. Well-designed epidemiological studies limited to allergic drug reactions are lacking; most of the studies related to this problem have included all types of adverse drug reactions. The results of such studies should help us to identify patients at risk, particularly those at risk for severe reactions, and allow us to implement preventive measures. This review will summarize current knowledge on the incidence, prevalence, mortality and risk factors for hypersensitivity drug reactions. (c) 2005 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:626 / 632
页数:7
相关论文
共 82 条
[1]  
[Anonymous], 1991, Lancet, V337, P1308
[2]   Represcription of penicillin after allergic-like events [J].
Apter, AJ ;
Kinman, JL ;
Bilker, WB ;
Herlim, M ;
Margolis, DJ ;
Lautenbach, E ;
Hennessy, S ;
Strom, BL .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (04) :764-770
[3]  
ARONSON JK, 2002, DAVIDSONS PRINCIPLES, P147
[4]   Detection of patients with multiple drug allergy syndrome by elective tolerance tests [J].
Asero, R .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 80 (02) :185-188
[5]   Under-reporting of serious adverse drug reactions in Sweden [J].
Bäckström, M ;
Mjörndal, T ;
Dahlqvist, R .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (07) :483-487
[6]  
Barranco P., 1998, Clinical and Experimental Allergy, V28, P61
[7]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[8]   Anticonvulsant hypersensitivity syndrome: Lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment [J].
Bavdekar, SB ;
Muranjan, MN ;
Gogtay, NJ ;
Kantharia, V ;
Kshirsagar, NA .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (10) :1648-1650
[9]  
BIGBY M, 1986, JAMA-J AM MED ASSOC, V256, P3358
[10]   Immediate allergic reactions to betalactams: facts and controversies [J].
Blanca Gomez, Miguel ;
Torres, Maria J. ;
Mayorga, Critobalina ;
Perez-Inestrosa, Ezequiel ;
Suau, Rafael ;
Montanez, Maria, I ;
Juarez, Carlos .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 4 (04) :261-266